Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Anders

Showing results (121-130 of 271) with videos related to

Pageof 28
Sort By:
Pediatric Hematology and Oncology|December 17, 2021
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CMLStephanie M Smith, Shiqi Zhang, Vandana Sundaram, et al.
Pediatric Blood & Cancer|July 6, 2019
A psychosocial clinical care pathway for pediatric hematopoietic stem cell transplantationAnne E Kazak, Avi Madan Swain, Kimberly Canter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolateRui Yang, E Anders Kolb, Jing Qin, et al.
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Pediatric Blood & Cancer|August 26, 2015
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of OsteosarcomaMichael Roth, David M Barris, Sajida Piperdi, et al.
Bioinformatics Advances|May 30, 2023
Machine learning classifier approaches for predicting response to RTK-type-III inhibitors demonstrate high accuracy using transcriptomic signatures and <i>ex vivo</i> dataMauricio H Ferrato, Adam G Marsh, Karl R Franke, et al.
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Pageof 28

Showing results (121-130 of 271) with videos related to

Sort By:
Pageof 28
Pediatric Hematology and Oncology|December 17, 2021
Physician risk perceptions and surveillance practices for tyrosine kinase inhibitor long-term effects in pediatric CMLStephanie M Smith, Shiqi Zhang, Vandana Sundaram, et al.
Pediatric Blood & Cancer|July 6, 2019
A psychosocial clinical care pathway for pediatric hematopoietic stem cell transplantationAnne E Kazak, Avi Madan Swain, Kimberly Canter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2007
The folate receptor alpha is frequently overexpressed in osteosarcoma samples and plays a role in the uptake of the physiologic substrate 5-methyltetrahydrofolateRui Yang, E Anders Kolb, Jing Qin, et al.
European Journal of Medical Genetics|January 4, 2024
Therapeutic targeting in pediatric acute myeloid leukemia with aberrant HOX/MEIS1 expressionKristian L Juul-Dam, Neerav N Shukla, Todd M Cooper, et al.
Pediatric Blood & Cancer|July 21, 2023
Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasmsTodd M Cooper, Todd A Alonzo, Sarah K Tasian, et al.
Pediatric Blood & Cancer|August 26, 2015
Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of OsteosarcomaMichael Roth, David M Barris, Sajida Piperdi, et al.
Bioinformatics Advances|May 30, 2023
Machine learning classifier approaches for predicting response to RTK-type-III inhibitors demonstrate high accuracy using transcriptomic signatures and <i>ex vivo</i> dataMauricio H Ferrato, Adam G Marsh, Karl R Franke, et al.
Pediatric Blood & Cancer|May 4, 2011
Combination testing of cediranib (AZD2171) against childhood cancer models by the pediatric preclinical testing programChristopher L Morton, John M Maris, Stephen T Keir, et al.
Pediatric Blood & Cancer|June 2, 2011
Combination testing (Stage 2) of the Anti-IGF-1 receptor antibody IMC-A12 with rapamycin by the pediatric preclinical testing programE Anders Kolb, Richard Gorlick, John M Maris, et al.
Pediatric Blood & Cancer|July 9, 2015
Initial testing (stage 1) of the anti-microtubule agents cabazitaxel and docetaxel, by the pediatric preclinical testing programC Patrick Reynolds, Min H Kang, John M Maris, et al.
Pageof 28